1. Ананьева Л.П. Иксодовые клещевые боррелиозы (Лаймская болезнь). Экология, клиническая картина и этиология. Тер. архив. 2000; № 5: С. 72-78.
2. Коренберг Э.И. Инфекции группы Лайм боррелиоза -иксодовые клещевые боррелиозы в России. Мед. паразитология и паразитарные болезни. 1996; №3: С.14-18.
3. Руководство по инфекционным болезням. Под ред. член-корр. РАМН профессора Ю.В. Лобзина. 4-е издание доп. и перераб. СПб: «Издательство Фолиант», 2011; С.567-590.
4. Скрипченко Н.В., Иванова Г.П. Клещевые инфекции у детей. Руководство для врачей. М.: Медицина, 2008; 424 с.
5. Усков А.Н. Смешанные инфекции, передающиеся иксодовыми клещами в Северозападном регионе России (клиника, диагностика, лечение). Дис. д.м.н. СПб., 2003; 395 с.
6. LaRocca T., Benach J. The important and diverse roles of antibodies in the host response to Borrelia infections. Curr. Top. Microbiol. Immunol. 2008; 319: 63-103.
7. Sood S.K. Lyme Disease in Children. Infect Dis Clin N Am. 2015; 29: 281-294.
8. Онищенко Г.Г. Распространение вирусных природно-очаговых инфекций в Российской Федерации и меры по их профилактике. Эпидемиология и инфекц. болезни. 2000; № 4: С.4-8.
9. Скрипченко Н..В., Иванова Г.П., Трофимова Т.Н. Клиниколучевые аспекты лейкоэнцефалитов у детей. Нейроиммунология. 2008; Том VI, №1-2: С.27-35.
10. Lantos P.M., (http://cid.oxfordjournals.org/search? author1=Paul+M.+Lantos&sortspec=date&submit=Submit) Medoff G. et al. Final Report of the Lyme Disease Review Panel of the Infectious Diseases Society of America Clin Infect Dis. 2010; 51 (1): 1-5. doi: 10.1086/654809 (http://cid.oxfordjournals.org/search? author1=Gerald+Medoff&sortspec=date&submit=Submit)
11. Mygland A, Lj0stad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I; European Federation of Neurological Societies. (http://cid.oxfordjournals.org/search? author1=Gerald+Medoff&sortspec=date&submit=Submit) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis . Eur J Neurol. 2010; 17: 8-16. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
12. Воробьева Н.Н., Главатских И.А., Мышкина О.К., Рысинская Т.К. Стандарты диагностики и лечения больных клещевым энцефалитом и иксодовыми клещевыми боррелиозами. Рос. мед. журн. 2000; № 4: С.22-24. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
13. Tugwell P., Dennis D.T., Weinstein A., et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997; 127: 110923. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468- 1331.2009.02862.x/pdf)
14. Nowakowski J., Schwartz I., Liveris D., et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis. 2001; 33: 2023-7. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
15. Luft B.J., Dattwyler R.J., Johnson R.C., et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial. Ann Intern Med. 1996; 124: 785-91. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
16. Mullegger R.R., Millner M.M., Stanek G., Spork K.D. Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children—a prospective study. Infection. 1991; 19: 279-83. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
17. Dattwyler R.J., Volkman D.J., Conaty S.M., Platkin S.P., Luft B.J. Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet. 1990; 336: 1404-6. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
18. Nadelman R.B., Luger S.W., Frank E., Wisniewski M., Collins J.J., Wormser G.P. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med. 1992; 117: 273-80. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468- 1331.2009.02862.x/pdf)
19. Lj0stad U., Skogvoll E., Eikeland R., et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008; 7: 690-5. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
20. Kowalski T.J., Tata S., Berth W., Mathiason M.A., Agger W.A. Antibiotic treatment duration and long-term outcomes of patients with early Lyme disease from a Lyme disease-hyperendemic area. Clin Infect Dis. 2010; 50: 512-20. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
21. Rohacova H., Hancil J., Hulinska D., Mailer H., Havlik J. Ceftriaxone in the treatment of Lyme neuroborreliosis. Infection. 1996; 24: 8890. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468- 1331.2009.02862.x/pdf)
22. Schofield S. and Plourde P. Statement on personal protective measures to prevent arthropod bites. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2012; 38: 1-18. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
23. Bissinger B.W. and Roe R.M. Tick repellents: past, present, and future. Pestic Biochem Physiol. 2010; 96: 63-79. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
24. Pages F., Dautel H., Duvallet G., et al: Tick repellents for human use: prevention of tick bites and tick-borne diseases. Vector Borne Zoonotic Dis. 2014; 14: 85-93. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
25. Hinckley A.F., Meek J.I., Ray J.A. et al. Efectiveness of Residential Acaricides to Prevent Lyme and Other Tick-borne Diseases in Humans. J. Infect. Dis. 2016; 214 (2): 182-214. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)
26. Vazquez M., Muehlenbein C., Cartter M., Hayes E.B., Ertel S., Shapiro E.D. Effectiveness of personal protective measures to prevent Lyme disease. Emerg Infect Dis. 2008; 14: 210-6. (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2009.02862.x/pdf)